27 Jan 2017 07:00
Omega Diagnostics Group PLC
("Omega" or the "Company")
Update on discussions with Immunodiagnostic Systems Holdings plc
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following update on its discussions with Immunodiagnostic Systems Holdings plc ("IDS").
Further to the interims results announcement in November 2016, IDS has confirmed that its preferred course of action is to pursue an enlarged distribution relationship with the Company. Currently, IDS has contractual rights to be appointed as the Company's exclusive distributor in territories comprising the UK, France, Germany, Austria, Switzerland, Nordic countries and the United States of America. The ongoing discussions will therefore focus on how Omega can attain a more global reach for its Allersys® range of allergy tests in a structure that benefits both organisations.
Currently, the Company has 41 CE-Marked allergy tests which can be run on the IDS iSYS automated instrument. The Company will provide a further update in due course.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
Jag Grewal, Group Sales and Marketing Director |
|
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) | |
Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |